The present invention relates to novel glucagon peptides, to the use of said glucagon peptides in therapy, to methods of treatment comprising administration of said glucagon peptides to patients in need thereof, and to the use of said glucagon peptides in the manufacture of medicaments. The glucagon peptides of the present invention are of particular interest in relation to the treatment of hyperglycemia, diabetes and obesity, as well as a variety of diseases or conditions associated with hyperglycemia, diabetes and obesity.本發明係關於新穎升糖素肽、該等升糖素肽在治療中之用途、包含向有此需要之患者投予該等升糖素肽之治療方法及該等升糖素肽在製造醫藥品中之用途。本發明之升糖素肽尤其關於高血糖症、糖尿病及肥胖以及與高血糖症、糖尿病及肥胖相關之各種疾病或病況之治療受到關注。
